1 – 39 of 39
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Lars R Holsti (1926-2023), Big name in Finnish and Nordic oncology
(
- Contribution to journal › Letter
- 2013
-
Mark
Prioritering av ALF-medel gynnsamt för kliniska forskare.
(
- Contribution to journal › Article
- 2005
-
Mark
Motives for becoming and remaining member of patient associations: a study of 1,810 Swedish individuals with cancer associations.
(
- Contribution to journal › Article
- 2002
-
Mark
Validering av ny prognostisk modell i lymfkörtelnegativ bröstcancer baserad på automatiskt utvärderade DNA flödescytometriska data
2002) Svenska Läkaresällskapets Riksstämma(
- Contribution to conference › Poster
- 2001
-
Mark
Voluntary associations for cancer patients in Sweden: supportive activities
(
- Contribution to journal › Article
- 1999
-
Mark
Chromosomal aberrations in breast cancer: a comparison between cytogenetics and comparative genomic hybridization
(
- Contribution to journal › Article
- 1998
-
Mark
Genetic aberrations in hypodiploid breast cancer: frequent loss of chromosome 4 and amplification of cyclin D1 oncogene
(
- Contribution to journal › Article
-
Mark
Proliferative index obtained by DNA image cytometry. Does it add prognostic information in Auer IV breast cancer?
(
- Contribution to journal › Article
- 1997
-
Mark
Identification of TP53 gene mutations in uterine corpus cancer with short follow-up
(
- Contribution to journal › Article
-
Mark
Flow cytometric S-phase fraction in soft-tissue sarcoma: prognostic importance analysed in 160 patients
(
- Contribution to journal › Article
- 1996
-
Mark
Urokinase plasminogen activator, a strong independent prognostic factor in breast cancer, analysed in steroid receptor cytosols with a luminometric immunoassay
(
- Contribution to journal › Article
-
Mark
Methodological aspects of flow cytometry DNA analysis in endometrial carcinoma, with special reference to sampling and reproducibility
(
- Contribution to journal › Article
-
Mark
Preoperative fine needle aspiration from human breast cancer is a valuable sampling material for progesterone receptor and cytometric DNA analysis
(
- Contribution to journal › Article
- 1995
-
Mark
A Phase I/II Evaluation of Metoclopramide as a Radiosensitiser in Patients with Inoperable Squamous Cell Carcinoma of the Lung
(
- Contribution to journal › Article
-
Mark
Recurrence-free survival in breast cancer improved by adjuvant tamoxifen--especially for progesterone receptor positive tumors with a high proliferation
(
- Contribution to journal › Article
-
Mark
The prognostic information of DNA ploidy and S-phase fraction may vary with histologic grade in endometrial carcinoma
(
- Contribution to journal › Article
- 1994
-
Mark
Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancer. South Sweden Breast Cancer Group
(
- Contribution to journal › Article
-
Mark
ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer
(
- Contribution to journal › Article
- 1993
-
Mark
Comparative cytogenetic and DNA flow cytometric analysis of 150 bone and soft-tissue tumors
(
- Contribution to journal › Article
- 1992
-
Mark
Flow cytometry DNA analysis and prediction of loco-regional recurrences after mastectomy in breast cancer
(
- Contribution to journal › Article
-
Mark
Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry
(
- Contribution to journal › Article
-
Mark
Prognostic potential of flow cytometric S-phase and ploidy prospectively determined in primary breast carcinomas
(
- Contribution to journal › Article
-
Mark
Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome
(
- Contribution to journal › Article
-
Mark
One or multiple samplings for flow cytometric DNA analyses in breast cancer-prognostic implications?
(
- Contribution to journal › Article
-
Mark
Comparison of BrdUrd and [3H]TdR incorporation to estimate cell proliferation, cell loss, and potential doubling time in tumor xenografts
(
- Contribution to journal › Article
-
Mark
Prognostic significance of flow cytometric DNA analysis and estrogen receptor content in breast carcinomas--a 10 year survival study
(
- Contribution to journal › Article
- 1991
-
Mark
ERBB2 amplification in breast cancer with a high rate of proliferation
(
- Contribution to journal › Article
-
Mark
Proliferation and DNA ploidy in malignant breast tumors in relation to early oral contraceptive use and early abortions
(
- Contribution to journal › Article
-
Mark
Association of int2/hst1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis
(
- Contribution to journal › Article
-
Mark
DNA ploidy assessment of breast milk (colostrum) in primiparous women of different ages
(
- Contribution to journal › Article
- 1990
-
Mark
Indicators of prognosis in node-negative breast cancer
(
- Contribution to journal › Article
-
Mark
Cellular DNA content and prognosis of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience
(
- Contribution to journal › Article
-
Mark
Improved preparation technique of cervical carcinoma for flow cytometric DNA analysis with tissue disintegration in hydrochloric acid
(
- Contribution to journal › Article
-
Mark
Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levels
(
- Contribution to journal › Article
-
Mark
Prognostic indicators in node-negative breast cancer (Reply)
(
- Contribution to journal › Letter
-
Mark
HER-2/neu amplification predicts poor survival in node-positive breast cancer
(
- Contribution to journal › Article
- 1989
-
Mark
Flow cytometric DNA ploidy and number of cell populations in the primary breast cancer and their correlation to the prognosis.
(
- Contribution to journal › Article
-
Mark
HER2/neu amplification and comedo type breast carcinoma
(
- Contribution to journal › Letter
-
Mark
Tissue diagnostics using laser-induced fluorescence
1989) Discussion Meeting of The Deutsche Bunsen-Gesellschaft fuer Physikalische Chemie In Berichte der Bunsengesellschaft für Physikalische Chemie 93(3). p.335-342(
- Contribution to journal › Article